$25 Million

Stereotaxis, Inc.

PIPE

Sole Placement Agent, August 2019

Stereotaxis, Inc. is an electrophysiology (EP) company focused on developing and commercializing innovative robotic technologies designed to enhance the treatment of arrythmias and perform endovascular procedures. The technology utilizes externally applied magnetic fields to govern the motion of the working tip of the catheter, resulting in improved navigation, efficient procedures and reduced x-ray exposure. The Company’s core technologies include the Niobe ES remote magnetic navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems and the Vdrive robotic navigation system and consumables.